# Pilot Study Reduced Fluence PDT /Visudyne With Ranibizumab vs Ranibizumab Monotherapy for Exudative Age-related Macular Degeneration (AMD)

> **NCT00726973** · NA · WITHDRAWN · sponsor: **Lahey Clinic**

## Conditions studied

- Macular Edema

## Interventions

- **DRUG:** Ranibizumab
- **DRUG:** Ranibizumab monotherapy

## Key facts

- **NCT ID:** NCT00726973
- **Lead sponsor:** Lahey Clinic
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2006-12
- **Primary completion:** 2012-07
- **Final completion:** 2012-07
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Unable to recruit study participants
- **Last updated:** 2012-05-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00726973

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00726973, "Pilot Study Reduced Fluence PDT /Visudyne With Ranibizumab vs Ranibizumab Monotherapy for Exudative Age-related Macular Degeneration (AMD)". Retrieved via AI Analytics 2026-09-04 from https://api.ai-analytics.org/clinical/NCT00726973. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*